Molecular Genetics and Metabolism Reports (Mar 2023)

Total and reduced/oxidized forms of coenzyme Q10 in fibroblasts of patients with mitochondrial disease

  • Chika Watanabe,
  • Hitoshi Osaka,
  • Miyuki Watanabe,
  • Akihiko Miyauchi,
  • Eriko F. Jimbo,
  • Takeshi Tokuyama,
  • Hideki Uosaki,
  • Yoshihito Kishita,
  • Yasushi Okazaki,
  • Takanori Onuki,
  • Tomohiro Ebihara,
  • Kenichi Aizawa,
  • Kei Murayama,
  • Akira Ohtake,
  • Takanori Yamagata

Journal volume & issue
Vol. 34
p. 100951

Abstract

Read online

Coenzyme Q10 (CoQ10) is involved in ATP production through electron transfer in the mitochondrial respiratory chain complex. CoQ10 receives electrons from respiratory chain complex I and II to become the reduced form, and then transfers electrons at complex III to become the oxidized form. The redox state of CoQ10 has been reported to be a marker of the mitochondrial metabolic state, but to our knowledge, no reports have focused on the individual quantification of reduced and oxidized CoQ10 or the ratio of reduced to total CoQ10 (reduced/total CoQ10) in patients with mitochondrial diseases.We measured reduced and oxidized CoQ10 in skin fibroblasts from 24 mitochondrial disease patients, including 5 primary CoQ10 deficiency patients and 10 respiratory chain complex deficiency patients, and determined the reduced/total CoQ10 ratio.In primary CoQ10 deficiency patients, total CoQ10 levels were significantly decreased, however, the reduced/total CoQ10 ratio was not changed. On the other hand, in mitochondrial disease patients other than primary CoQ10 deficiency patients, total CoQ10 levels did not decrease. However, the reduced/total CoQ10 ratio in patients with respiratory chain complex IV and V deficiency was higher in comparison to those with respiratory chain complex I deficiency.Measurement of CoQ10 in fibroblasts proved useful for the diagnosis of primary CoQ10 deficiency. In addition, the reduced/total CoQ10 ratio may reflect the metabolic status of mitochondrial disease.

Keywords